COMMUNIQUÉS West-GlobeNewswire

DBV Technologies to Participate in Upcoming March Investor Conferences
04/03/2026
Châtillon, France, March 4, 2026 DBV Technologies to Participate in Upcoming March Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a late-stage biopharmaceutical [...]
MAIA Biotechnology Announces Closing of $30 Million Underwritten Public Offering of Common Stock
04/03/2026
Financing included participation by healthcare-dedicated investors alongside existing shareholders CHICAGO, IL, March 04, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company [...]
Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment
04/03/2026
Indomo Developing Fast-Acting, At-Home Treatment for Inflammatory Acne Lesions to be Administered with the ClearPen ™ , its Proprietary Intradermal Self-Injection Device Lifecore to Manufacture Drug Batches in [...]
Sotera Health Announces Secondary Offering of Common Stock
04/03/2026
CLEVELAND, March 04, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 25 million shares of its common stock, par value $ [...]
Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference
04/03/2026
IRVINE, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, and Steven Perrin, Ph.D., President [...]
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
04/03/2026
LEXINGTON, Mass., March 04, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel [...]
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
04/03/2026
NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective March 1, 2026, in [...]
Castle Biosciences to Present Data at SSO 2026 on DecisionDx®-Melanoma’s i31-SLNB, Identifying T1b–T2a Melanoma Patients Who May Safely Avoid SLNB
04/03/2026
FRIENDSWOOD, Texas, March 04, 2026 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that new data evaluating [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
04/03/2026
ZUG, Switzerland, March 04, 2026 (GLOBE NEWSWIRE) -- The attached notification relates to the vesting and settlement of RSUs previously granted to a director of the Company. Attachment Notification of managers' [...]
SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update
04/03/2026
SCYNEXIS received a one-time non-refundable payment in Q4 2025 totalling $24.8 million from GSK SCYNEXIS announced dosing of the first patient using the intravenous (IV) formulation of SCY-247 in a Phase 1 study and [...]
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025
04/03/2026
PORTLAND, Maine, March 04, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
04/03/2026
(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 04 mars 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]
Galapagos Receives Transparency Notifications from Bank of America
04/03/2026
Mechelen, Belgium ; March 4, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America. Pursuant to Belgian transparency legislation 1 [...]
Los Angeles Orthodontist McComb Orthodontics Reaches 5,000 Invisalign Cases, Earns Sapphire Status
04/03/2026
LOS ANGELES, March 04, 2026 (GLOBE NEWSWIRE) -- Invisalign provider McComb Orthodontics , a specialty orthodontic practice with clinics in West Hollywood and Culver City, has reached Sapphire status, Invisalign’s [...]
Predictors of Success for 60-Day Peripheral Nerve Stimulation (PNS) Used for Treatment of Chronic Shoulder Pain: A Multi-Center Retrospective Chart Review
04/03/2026
- Bimodal stimulation produced significantly higher shoulder pain relief compared to other stimulation paradigms - CLEVELAND, March 04, 2026 (GLOBE NEWSWIRE) -- Shoulder pain is one of the most common locations of [...]
Coloplast appoints Gavin Wood as new CEO
04/03/2026
Announcement no. 3/2026 Inside information Coloplast appoints Gavin Wood as new CEO The Coloplast Board of Directors is pleased to announce the appointment of Gavin Wood as the new President and Chief Executive Officer [...]
Bioxytran Announces Positive Dose Optimization Results and Advances Toward Phase 3 Registrational Trial for ProLectin-M
04/03/2026
Company Initiates Regulatory Discussions with CDSCO; Plans 408-Patient Pivotal Study Targeting Standard-Risk Several Viral Infected Outpatients BOSTON, March 04, 2026 (GLOBE NEWSWIRE) -- Bioxytran, Inc. (OTCQB: BIXT) [...]
Press Release: Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report
04/03/2026
Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report Paris, March 4, 2026 . Sanofi announces today the filing of an amendment to its “Document d’ [...]
Communiqué de presse : Dépôt d’un amendement au Document d’Enregistrement Universel 2025, contenant le Rapport Financier Annuel
04/03/2026
Dépôt d’un amendement au Document d’Enregistrement Universel 2025, contenant le Rapport Financier Annuel Paris, le 4 mars 2026 . Sanofi annonce avoir déposé ce jour un amendement à son Document d’Enregistrement [...]

Pages